))
TechNation Radio hosted by Dr Moira Gunn
…
continue reading
Welcome to BIOTECH NATION !!! With understandable interviews requiring no background in science, BTN attracts a wide global audience. From everyday people looking for hope in treatments in development, to bioentrepreneurs interested in the experience of their fellow travelers, to venture capitalists looking for possibilities in cutting-edge breakthroughs, to scientists simply interested in the work of others, BioTech Nation is the voice of human endeavor, driving science to new realities for ...
…
continue reading
BioTech Nation Radio with Dr Moira Gunn
…
continue reading
1
A Dual Approach to Combatting Hepatitis... Dr. Marianne De Backer, CEO at Vir Biotechnology
19:52
19:52
Play later
Play later
Lists
Like
Liked
19:52
This week on Biotech Nation, Dr. Marianne De Backer, CEO of Vir Biotechnology talks about their Phase 2 clinical trials targeting hepatitis B and D co-infections. Vir's approach uses two drugs: tobevibart (an antibody) and elebsiran (an siRNA). These drugs prevent the virus from entering liver cells and stop it from replicating. Preliminary results…
…
continue reading
Neuroscientist and Author Dr. Kelly Clancy joins me to discuss the role that games have played in human development. Her book is “Playing with Reality … How Games Have Shaped Our World.” Then, Dr. Marianne De Backer, CEO of Vir Biotechnology, explains how serious it can be when a person carries both Hepatitis B and Hepatitis D and what Vir is doing…
…
continue reading
On this week’s Tech Nation, Moira speaks with Author, Elaine Lin Hering, joins me to talk about her book, “Unlearning Silence … How to Speak Your Mind, Unleash Talent, and Live More Fully.” Then, Dr. Neil Kumar, Founder and CEO of BridgeBio Pharma, explains why we can expect genetic diseases to be solvable in our lifetime.…
…
continue reading
1
Solving Genetic Diseases??? Dr. Neil Kumar, Founder & CEO, BridgeBio Pharma
23:18
23:18
Play later
Play later
Lists
Like
Liked
23:18
This week on Biotech Nation, Dr. Neil Kumar, founder and CEO of BridgeBio Pharma. Dr. Kumar emphasizes that genetic diseases, particularly Mendelian diseases caused by single gene mutations, are solvable due to advancements in genetic measurement and understanding. He discusses BridgeBio Pharma's innovative corporate structure, which consists of mu…
…
continue reading
On this week’s Tech Nation, Moira speaks with Stanford Business School Lecturer, Matt Abrahams, about his book, “THINK FASTER, TALK SMARTER: How To Speak Successfully When You’re Put on the Spot”. Then, Dr. Steffen-Sebastian Bolz from Aphaia Pharma talks about their new drug, currently in phase 3 trial, that may provide the benefits of Ozempic and …
…
continue reading
1
The Next Ozempic or Wegovy... But Without the Injection??? Dr. Steffen-Sebastian Bolz, CSO, Aphaia Pharma
25:16
25:16
Play later
Play later
Lists
Like
Liked
25:16
What’s next after Ozempic and Wegovy and the like? How about a drug in development which releases all the relevant hormones, and not just GLP-1. And doesn’t require injecting. Dr. Steffen-Sebastian Bolz from Aphaia (ah-phi-ah) Pharma explains their approach, currently in Phase 2.By Moira Gunn
…
continue reading
1
FDA Approval! A New Model for BioPharma... Dr. Sam Blackman, Founder & Head of Research and Development, One Day Biopharmaceuticals
31:10
31:10
Play later
Play later
Lists
Like
Liked
31:10
This week on BioTech Nation, Dr. Sam Blackman, Founder and Head of Research and Development from Day One Biopharmaceuticals, shares the story behind the FDA approval of a groundbreaking drug for the most common childhood brain cancer. He talks about their innovative approach to starting a biopharma company and how it led to a newly FDA approved dru…
…
continue reading
1
Everybody Has a Thyroid... What Could Go Wrong??? Dr. Mark Sumeray, CMO of Amolyt Pharma
28:59
28:59
Play later
Play later
Lists
Like
Liked
28:59
This week we have a best of rerun with Dr. Mark Sumeray from Amolyt Pharma. Dr. Sumeray talks about their innovative approach to treating hormonal conditions. We’ll talk about two – when your parathyroid has been injured or removed, often during thyroid surgery, and another – when the pituitary starts overproducing growth hormone.…
…
continue reading
Stanford Professor Robert Sapolsky about “Determined: A Science of Life Without Free Will”. Then, Tech Nation Health Chief Correspondent Dr. Daniel Kraft talks about how Medical Schools decide what to teach.
…
continue reading
On this week’s Tech Nation, Moira speaks with Journalist Alex Kantrowitz about his 2020 book, “Always Day One: How the Tech Titans Plan to Stay on Top Forever” which has spawned his work, as Founder and Editor of Big Technology. Then, Dr. Mark Sumeray, Chief Medical Officer of Amolyt Pharma, talks about their innovative approach to treating hormona…
…
continue reading
1
Wearable Wonders! Dr. Daniel Kraft, Tech Nation Health Chief Correspondent
13:38
13:38
Play later
Play later
Lists
Like
Liked
13:38
This week Dr. Daniel Kraft, Tech Nation Health Chief Correspondent, discusses advanced health tech. Dr. Kraft highlights his use of wearables like the Apple Watch, Oura ring, and non-invasive blood pressure monitors. He also introduces "otherables," which track health without being worn, using devices like cameras and modified WiFi. These technolog…
…
continue reading
On this week’s Tech Nation, Moira speaks with Science journalist and author, Annalee Newitz, joins me to talk about her book, “Stories are Weapons … Psychological Warfare and the American Mind”. Then, Tech Nation Health Chief Correspondent Dr. Daniel Kraft talks about the latest in Wearables, what they are doing now that they weren’t doing before.…
…
continue reading
1
Robo-Docs & VR Surgery??? Dr. Daniel Kraft, Tech Nation Health Chief Correspondent
13:56
13:56
Play later
Play later
Lists
Like
Liked
13:56
This week on BioTech Nation, Dr. Moira Gunn and Dr. Daniel Kraft discuss how robotics, AI, and virtual reality are transforming surgery. These technologies make procedures less invasive and improve training and outcomes worldwide. Future advancements may include tiny robots performing internal procedures. Security is crucial to prevent hacking of m…
…
continue reading
1
Episode 24-22 FDA Approved! A New Model for Biopharma
59:00
59:00
Play later
Play later
Lists
Like
Liked
59:00
On this week’s Tech Nation, Moira speaks with Dr. Sam Blackman, Founder and Head of Research and Development from Day One Biopharmaceuticals talks about their innovative approach to starting a biopharma company and how it led to a newly FDA approved drug that treats the most common form of brain cancer in children. Then, Dr. Daniel Kraft, Tech Nati…
…
continue reading
On this week’s Tech Nation, Moira speaks with Mustafa Suleyman, CEO of Inflection AI, about “The Coming Wave … Technology, Power, and the 21st Century’s Greatest Dilemma”. Then, Bloomberg columnist Adam Minter talks about his 2019 book, “Secondhand: Travels in the New Global Garage Sale.” You dropped it off at the thrift store … where does it go fr…
…
continue reading
1
No More Transfusions!!! Dr. John Scarlett, President and CEO of Geron Corporation
16:10
16:10
Play later
Play later
Lists
Like
Liked
16:10
Dr. John Scarlett, President and CEO of Geron Corporation talks about their drug Imetelstat for myelodysplastic syndrome (MDS). MDS patients often require frequent blood transfusions, impacting their quality of life. Imetelstat, a telomerase inhibitor, aims to reduce transfusion dependence by targeting cancer cells in the bone marrow. Phase three t…
…
continue reading
1
Episode 24-20 Climate Change’s Impact on Sports
59:00
59:00
Play later
Play later
Lists
Like
Liked
59:00
On this week’s Tech Nation, Moira speaks with Sports ecology professor and author Dr. Madeleine Orr, about her book, “Warming Up… How Climate Change is Changing Sport”. Then, Tech Nation Health Chief Correspondent Dr. Daniel Kraft talks about the Medical Innovation Gap, which is the time from innovation until we actually can use it in everyday prac…
…
continue reading
1
Closing the Innovation Gap!!! Dr. Daniel Kraft, Tech Nation Health Chief Correspondent
10:26
10:26
Play later
Play later
Lists
Like
Liked
10:26
Dr. Daniel Kraft, Tech Nation Health Chief Correspondent discusses the gap between medical innovation and its adoption into standard practice. He highlights that it typically takes 17 years for a medical discovery to become common practice, but big data and AI could accelerate this. He emphasizes the importance of sharing medical data and initiativ…
…
continue reading
1
The Virtual Cell??? Dr. Steve Quake, Head of Science at Chan Zuckerberg Initiative
21:21
21:21
Play later
Play later
Lists
Like
Liked
21:21
This week, Dr. Steve Quake from the Chan Zuckerberg Initiative about their goal to tackle all human diseases in the next century. We discuss CZI's innovative approach, including building Biohubs and funding collaborative research. Dr. Quake explains the importance of something called The Virtual Cell project, aiming to use AI to model every human c…
…
continue reading
On this week’s Tech Nation, Moira speaks with Pulitzer-Prize winning author, Ed Humes, talks about his book, “Total Garbage… How We Can Fix Our Waste and Heal Our World.” Then, Dr. Steve Quake, Head of Science at the Chan Zuckerberg Initiative tells us about their ambitious goal to address all human diseases within the next century.…
…
continue reading
1
Episode 24–18 Focused Ultrasound Treatments
59:00
59:00
Play later
Play later
Lists
Like
Liked
59:00
On this week’s Tech Nation, Moira speaks with Dr. Neil Kassell, the founder and chair of the Focused Ultrasound Foundation, about what focused ultrasound is and the different ways in which it is being used. Then, Dr. Nicholas Dirks, the President and CEO of the New York Academy of Sciences, talks about such topics as the International Science Reser…
…
continue reading
1
How Can Sound Deliver Drugs??? Dr. Neal Kassell, Founder & Chair of Focused Ultrasound Foundation
16:48
16:48
Play later
Play later
Lists
Like
Liked
16:48
This week on Biotech Nation, I speak with Dr. Neal Kassell about focused ultrasound technology. We discuss its noninvasive approach, its diverse applications in treating various medical conditions, and its potential to revolutionize treatments for diseases like Alzheimer's, Parkinson's, and cancer. Dr. Kassell also shares insights into ongoing clin…
…
continue reading
1
Episode 24-17 Climate Change and Our Brain
59:00
59:00
Play later
Play later
Lists
Like
Liked
59:00
On this week’s Tech Nation, Moira speaks with Environmental journalist Clayton Page Aldern about his book, “The Weight of Nature … How a Changing Climate Changes Our Brains”. Then, Dr. Sean Bohen, President & CEO of Olema Oncology, talks about what we’ve learned about the 70% of breast cancers, called ER+/HER2- and how it relates to prostate cancer…
…
continue reading
1
Episiode 24-16 Amazon or Walmart - who's got the tech?
59:00
59:00
Play later
Play later
Lists
Like
Liked
59:00
On this week’s Tech Nation, Moira speaks with journalist Jason Del Rey about Amazon and Walmart - how they are different and their designs on your attention. His book is “Winner Sells All: Amazon, Walmart, and the Battle for Our Wallets”. Then, in biotech, breakthrough science changes the name of the game on how to make a medicine. Dr. Sanjay Shukl…
…
continue reading
1
70% of Breast Cancers and a Link to Prostate Cancer... Dr. Sean Bohen, President & CEO, Olema Oncology
23:02
23:02
Play later
Play later
Lists
Like
Liked
23:02
This week on BioTech Nation, we explore new efforts in treating cancer with Dr. Sean Bohen, President and CEO of Olema Oncology. We discuss progress in treating breast cancer, particularly ER+/HER2- breast cancer, which accounts for 70% of diagnoses this year. They examine the biology behind these cancers and how Olema's lead compound, palazestrant…
…
continue reading
1
Tiny RNAs, Big Cures!!! Dr. Sanjay Shukla, President and CEO, ATyr (ah-tire) Pharma
19:54
19:54
Play later
Play later
Lists
Like
Liked
19:54
This week - Dr. Sanjay Shukla, CEO of Atyr Pharma, discusses the revolutionary potential of mRNA technology in creating new medicines. They explore Atyr's pioneering approach to leveraging tRNA fragments for treating pulmonary sarcoidosis and other organ-specific conditions, aiming to improve patient outcomes while minimizing reliance on convention…
…
continue reading
On this week’s Tech Nation, Moira speaks with Warren Berger, author of “A More Beautiful Question … The Power of Inquiry to Spark Breakthrough Ideas” now in its tenth anniversary re-release and update. Then, Dr. Peter DeMuth, Chief Scientific Officer at Elicio Therapeutics, tells us about how a treatment can turn into a vaccine and potentially prov…
…
continue reading
1
How Can a Treatment Become a Vaccine??? Dr. Peter DeMuth, Chief Scientific Officer at Elicio Therapeutics
23:33
23:33
Play later
Play later
Lists
Like
Liked
23:33
Dr. Peter DeMuth, Chief Scientific Officer of Elicio Therapeutics, discusses the revolutionary approach of detecting cancer at its earliest stages through circulating tumor DNA (ctDNA) tests. Highlighting their innovative treatment method, which aims to train the body's immune cells to recognize and destroy cancer cells, the episode explores the po…
…
continue reading
On this week’s Tech Nation, Moira speaks with Dr. Dan Reidenberg (Rye-den-berg), Project Director for Safe Online Standards at the Mental Health Coalition talks about what young people are doing online and how to keep them safe. Then, Dr. Chris Pirie, the Co-Founder and COO of HDTBio tells us what it takes to build a cancer vaccine.…
…
continue reading
1
Cancer Vaccines??? Dr. Chris Pirie, Co-Founder & COO of HDT Bio
17:08
17:08
Play later
Play later
Lists
Like
Liked
17:08
In this week's episode, Dr. Moira Gunn interviews Dr. Chris Pirie from HDT Bio about their novel approach to cancer prevention through vaccines. They discuss leveraging mRNA technology to target specific tumor mutations and prime the immune system to recognize and eliminate cancer cells. Dr. Pirie highlights ongoing efforts to develop vaccines for …
…
continue reading
On this week’s Tech Nation, Moira speaks with Dr. Soren Kaplan talks about taking a look at your life experience to gain insight and action into your personal and business life. His book is “Experiential Intelligence: Harness the Power of Experience for Personal and Business Breakthroughs.” Then to a place in Alaska where no human has gone, much le…
…
continue reading
1
Redefining Acute Myeloid Leukemia (AML) Treatment!!! Dr. Robert Ang, President & CEO of Vor Biopharma
15:20
15:20
Play later
Play later
Lists
Like
Liked
15:20
This week I speak with Dr. Robert Ang from Vor Biopharma about their innovative approach to treating acute myeloid leukemia (AML). AML is a type of blood cancer that affects the bone marrow, leading to the overgrowth of cancerous cells. Dr. Ang explains that traditional treatments, such as chemotherapy and stem cell transplants, have limitations an…
…
continue reading
1
Fighting Inflammation, and Alzheimer's??? Dr. David Bearss, President & CEO Halia Therapeutics
28:57
28:57
Play later
Play later
Lists
Like
Liked
28:57
In this week's episode of BioTech Nation, Dr. David Bearss, President and CEO of Halia Therapeutics, discusses inflammation and its reduction over a lifetime and in response to various incidents. He unveils the inflammasome, a recently discovered protein complex critical in regulating inflammatory responses and its potential in treating chronic dis…
…
continue reading
On this week’s Tech Nation, Moira speaks with Dr. David Bearss, President and CEO of Halia (Hah-lee-ah) Therapeutics, about their groundbreaking work, both in inflammation and in another drug to potentially resist Alzheimer’s. Then, Melissa Sevigny (Sev-inn-nee), Science Journalist and Author of “Brave the Wild River: The Untold Story of Two Women …
…
continue reading
